256 related articles for article (PubMed ID: 24323890)
1. Activation of GPR119 by fatty acid agonists augments insulin release from clonal β-cells and isolated pancreatic islets and improves glucose tolerance in mice.
Moran BM; Abdel-Wahab YH; Flatt PR; McKillop AM
Biol Chem; 2014 Apr; 395(4):453-64. PubMed ID: 24323890
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice.
McKillop AM; Moran BM; Abdel-Wahab YH; Flatt PR
Br J Pharmacol; 2013 Nov; 170(5):978-90. PubMed ID: 23992544
[TBL] [Abstract][Full Text] [Related]
3. The cytoprotective effects of oleoylethanolamide in insulin-secreting cells do not require activation of GPR119.
Stone VM; Dhayal S; Smith DM; Lenaghan C; Brocklehurst KJ; Morgan NG
Br J Pharmacol; 2012 Apr; 165(8):2758-70. PubMed ID: 22029844
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the insulin-releasing and glucose-lowering effects of GPR120 activation in pancreatic β-cells.
Moran BM; Abdel-Wahab YH; Flatt PR; McKillop AM
Diabetes Obes Metab; 2014 Nov; 16(11):1128-39. PubMed ID: 24919766
[TBL] [Abstract][Full Text] [Related]
5. Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells.
Ning Y; O'Neill K; Lan H; Pang L; Shan LX; Hawes BE; Hedrick JA
Br J Pharmacol; 2008 Dec; 155(7):1056-65. PubMed ID: 18724386
[TBL] [Abstract][Full Text] [Related]
6. A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release.
Chu ZL; Jones RM; He H; Carroll C; Gutierrez V; Lucman A; Moloney M; Gao H; Mondala H; Bagnol D; Unett D; Liang Y; Demarest K; Semple G; Behan DP; Leonard J
Endocrinology; 2007 Jun; 148(6):2601-9. PubMed ID: 17289847
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel GPR119 agonist, AS1269574, with in vitro and in vivo glucose-stimulated insulin secretion.
Yoshida S; Ohishi T; Matsui T; Shibasaki M
Biochem Biophys Res Commun; 2010 Sep; 400(3):437-41. PubMed ID: 20804735
[TBL] [Abstract][Full Text] [Related]
8. N-oleoyldopamine enhances glucose homeostasis through the activation of GPR119.
Chu ZL; Carroll C; Chen R; Alfonso J; Gutierrez V; He H; Lucman A; Xing C; Sebring K; Zhou J; Wagner B; Unett D; Jones RM; Behan DP; Leonard J
Mol Endocrinol; 2010 Jan; 24(1):161-70. PubMed ID: 19901198
[TBL] [Abstract][Full Text] [Related]
9. GPR39 receptors and actions of trace metals on pancreatic beta cell function and glucose homoeostasis.
Moran BM; Abdel-Wahab YH; Vasu S; Flatt PR; McKillop AM
Acta Diabetol; 2016 Apr; 53(2):279-93. PubMed ID: 26112416
[TBL] [Abstract][Full Text] [Related]
10. Bidirectional GPR119 Agonism Requires Peptide YY and Glucose for Activity in Mouse and Human Colon Mucosa.
Tough IR; Forbes S; Herzog H; Jones RM; Schwartz TW; Cox HM
Endocrinology; 2018 Apr; 159(4):1704-1717. PubMed ID: 29471473
[TBL] [Abstract][Full Text] [Related]
11. Novel GPR119 agonist HD0471042 attenuated type 2 diabetes mellitus.
Ha TY; Kim YS; Kim CH; Choi HS; Yang J; Park SH; Kim DH; Rhee JK
Arch Pharm Res; 2014 May; 37(5):671-8. PubMed ID: 23897163
[TBL] [Abstract][Full Text] [Related]
12. DS-8500a, an Orally Available G Protein-Coupled Receptor 119 Agonist, Upregulates Glucagon-Like Peptide-1 and Enhances Glucose-Dependent Insulin Secretion and Improves Glucose Homeostasis in Type 2 Diabetic Rats.
Matsumoto K; Yoshitomi T; Ishimoto Y; Tanaka N; Takahashi K; Watanabe A; Chiba K
J Pharmacol Exp Ther; 2018 Dec; 367(3):509-517. PubMed ID: 30217957
[TBL] [Abstract][Full Text] [Related]
13. AS1907417, a novel GPR119 agonist, as an insulinotropic and β-cell preservative agent for the treatment of type 2 diabetes.
Yoshida S; Tanaka H; Oshima H; Yamazaki T; Yonetoku Y; Ohishi T; Matsui T; Shibasaki M
Biochem Biophys Res Commun; 2010 Oct; 400(4):745-51. PubMed ID: 20816753
[TBL] [Abstract][Full Text] [Related]
14. Stimulating beta cell replication and improving islet graft function by GPR119 agonists.
Gao J; Tian L; Weng G; Bhagroo NV; Sorenson RL; O'Brien TD; Luo J; Guo Z
Transpl Int; 2011 Nov; 24(11):1124-34. PubMed ID: 21902730
[TBL] [Abstract][Full Text] [Related]
15. β-Cell Inactivation of
Panaro BL; Flock GB; Campbell JE; Beaudry JL; Cao X; Drucker DJ
Diabetes; 2017 Jun; 66(6):1626-1635. PubMed ID: 28254842
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological potential of novel agonists for FFAR4 on islet and enteroendocrine cell function and glucose homeostasis.
McCloskey AG; Miskelly MG; Flatt PR; McKillop AM
Eur J Pharm Sci; 2020 Jan; 142():105104. PubMed ID: 31669388
[TBL] [Abstract][Full Text] [Related]
17. Agonists at GPR119 mediate secretion of GLP-1 from mouse enteroendocrine cells through glucose-independent pathways.
Lan H; Lin HV; Wang CF; Wright MJ; Xu S; Kang L; Juhl K; Hedrick JA; Kowalski TJ
Br J Pharmacol; 2012 Apr; 165(8):2799-807. PubMed ID: 22029751
[TBL] [Abstract][Full Text] [Related]
18. Novel GPR119 agonist AS1669058 potentiates insulin secretion from rat islets and has potent anti-diabetic effects in ICR and diabetic db/db mice.
Oshima H; Yoshida S; Ohishi T; Matsui T; Tanaka H; Yonetoku Y; Shibasaki M; Uchiyama Y
Life Sci; 2013 Feb; 92(2):167-73. PubMed ID: 23246743
[TBL] [Abstract][Full Text] [Related]
19. 2-OMe-lysophosphatidylcholine analogues are GPR119 ligands and activate insulin secretion from βTC-3 pancreatic cells: Evaluation of structure-dependent biological activity.
Drzazga A; Sowińska A; Krzemińska A; Okruszek A; Paneth P; Koziołkiewicz M; Gendaszewska-Darmach E
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jan; 1863(1):91-103. PubMed ID: 29079451
[TBL] [Abstract][Full Text] [Related]
20. A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release.
Chu ZL; Carroll C; Alfonso J; Gutierrez V; He H; Lucman A; Pedraza M; Mondala H; Gao H; Bagnol D; Chen R; Jones RM; Behan DP; Leonard J
Endocrinology; 2008 May; 149(5):2038-47. PubMed ID: 18202141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
